AMENDED SETTLEMENT ALLOCATION AGREEMENTSettlement Allocation Agreement • April 5th, 2022 • Biofrontera Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 5th, 2022 Company Industry JurisdictionTHIS AMENDED SETTLEMENT ALLOCATION AGREEMENT (the “Agreement”) is made this 31st day of March, 2022, between Biofrontera Inc., a Delaware Corporation (“Inc”), and Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH, Biofrontera Neuroscience GmbH, each a limited liability company organized under the laws of Germany, and Biofrontera AG (collectively, “AG”), a corporation organized and existing under the laws of Germany. Inc and AG may be individually referred to as a “Party” or collectively as the “Parties.”